Principles of Molecular Oncology: Second Edition by Laman, H
Book Review
Principles of Molecular Oncology: Second Edition
MH Bronchud, M Foote, G Giaccone, O Olopade and P Workman (editors)
Publisher: Humana Press. 2003. ISBN: 1-58829-279-7. $149.50
British Journal of Cancer (2004) 91, 1753. doi:10.1038/sj.bjc.6601866 www.bjcancer.com
& 2004 Cancer Research UK
             
This second edition of Principles of Molecular Oncology comes just
4 years after the first, and considering that we are now in the
‘postgenomics’ era, it does well to keep pace with the advances of
this rapidly evolving field. The text catalogues an amazing array of
molecular biology-inspired techniques and approaches for the
diagnosis, treatment, and understanding of cancer, which is even
more astounding when weighed against the fact that when DNA
was discovered 50 years ago, ‘cancer knowledge was based on
epidemiology and pathology, and treatment consisted of surgery
and radiation therapy.’ This text offers the reader a comprehensive
overview of how 25 years of molecular biology have been brought
to bear on the problems of this complex disease.
The opening chapter introduces the current state of affairs in
cancer biology, including its epidemiology, diagnosis and treat-
ment, the ‘older’ and ‘newer’ hypotheses surrounding its causes,
and the contributions of diet, viruses, nicotine/tobacco, and
hereditary predisposition to its development. Despite the vast
increase in our knowledge, the existing therapies have had a
relatively minor effect on mortality. As such, the anticipated dawn
of the ‘era of targeted therapies’ is eagerly awaited by all.
One kind of targeted or tailored approach is addressed in the
first section of the book, where molecular markers of cancers are
discussed. Realising that earlier detection is a major advantage in
cancer treatment, scientists are searching for more and better
markers to be used as both diagnostic and prognostic factors to
tailor the utility and efficacy of treatments. The identification of
markers in sporadic and heritable tumours, and in solid tumours
is discussed. Also, the hunt for circulating tumour markers to
assess tumour burden is detailed. Traditional approaches of
histological diagnosis and karyotyping are presented side by side
with the newer approaches of gene expression and protein
profiling.
The middle section of the book explains our molecular and
mechanistic understanding of the deregulated cellular pathways in
cancer development, including signal transduction pathways, cell
proliferation, angiogenesis, invasion/metastasis, drug resistance,
and genomic instability. As these are each robust areas of research,
there is a large amount of information here, and each of the
chapters is comprehensive and detailed in its dissection of these
recognised abnormalities of cancerous cells. Although some
chapters are more readable than others, in general the information
presented is concise and points the interested reader towards the
primary sources of information.
The final section deals with the therapies arising from molecular
biology. As researchers try to benefit from all this new
information, the hope is to move on from ‘scientifically interesting
to clinically useful.’ Although the approaches being taking are
research-driven, spanning suicide gene therapy, monoclonal
antibody therapies, and assisted drug-design and development,
understanding the function of a gene does not necessarily mean it
will be a good target for cancer treatment. This is a major
deficiency facing molecular oncologists today: with so many
possible genes, which represent the best, ‘druggable’ target on
which to focus our energies. Nevertheless, a trickle of next-
generation drugs, whose mechanisms of action are understood, are
emerging. These successes are hailed repeatedly and inspire the
hope that pervades this textbook and the field in general.
Despite the fact that there are 65 contributors to this edition of
Principles from Europe and America, it is highly readable, with
most of the chapters being well written and up-to-date, even listing
the newest compounds and their ongoing clinical trials. Each
chapter is well referenced, although the text is not very well
indexed, making it difficult to find particular genes or drugs
of interest within the chapters. As there are many authors, the
book is repetitive in places, but this only serves to underscore
the fundamental importance of certain pathways, like p53, in
cancer. Overall, this is a thorough treatment of a fast-moving and
exciting field. As such, it will appeal to clinicians and scientists,
and it should spur on young medical students or budding
researchers to the coming era of molecular approaches to human
diseases.
H Laman
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